Asset Allocation

As of December 31, 2024.
Type % Net
Cash 0.47%
Stock 40.11%
Bond 53.41%
Convertible 0.00%
Preferred 2.42%
Other 3.59%
View Asset Allocation
Start Trial

Market Capitalization

As of December 31, 2024
Large 61.97%
Mid 21.01%
Small 17.02%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 97.51%    % Emerging Markets: 0.55%    % Unidentified Markets: 1.94%

Americas 92.38%
91.34%
Canada 1.53%
United States 89.81%
1.03%
Mexico 0.54%
As of December 31, 2024. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 4.53%
United Kingdom 1.92%
2.61%
Ireland 0.75%
Italy 0.44%
Netherlands 0.03%
Sweden 0.00%
Switzerland 0.93%
0.00%
0.00%
Greater Asia 1.16%
Japan 0.00%
0.57%
Australia 0.57%
0.59%
Singapore 0.01%
Taiwan 0.58%
0.00%
Unidentified Region 1.94%

Bond Credit Quality Exposure

AAA 0.01%
AA 24.87%
A 3.89%
BBB 43.30%
BB 7.68%
B 4.53%
Below B 0.77%
    CCC 0.77%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.00%
Not Available 14.95%
Short Term 0.00%
As of December 31, 2024
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
37.71%
Materials
4.61%
Consumer Discretionary
4.32%
Financials
16.88%
Real Estate
11.89%
Sensitive
43.60%
Communication Services
0.63%
Energy
4.64%
Industrials
9.80%
Information Technology
28.53%
Defensive
18.30%
Consumer Staples
3.91%
Health Care
10.64%
Utilities
3.75%
Not Classified
0.39%
Non Classified Equity
0.23%
Not Classified - Non Equity
0.16%
As of June 30, 2024
View Region Exposure
Start Trial

Bond Sector Exposure

As of December 31, 2024
Type % Net
Government 28.09%
Corporate 49.28%
Securitized 4.67%
Municipal 0.00%
Other 17.96%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
4.78%
Less than 1 Year
4.78%
Intermediate
50.37%
1 to 3 Years
5.00%
3 to 5 Years
21.20%
5 to 10 Years
24.17%
Long Term
36.96%
10 to 20 Years
7.25%
20 to 30 Years
26.64%
Over 30 Years
3.07%
Other
7.88%
As of December 31, 2024
View Bond Maturity Exposure
Start Trial